Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: Comment on the article "Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis" by Bugatti et al.

4Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Castañeda, S., Llorente, I., García-Vicuña, R., & González-Álvaro, I. (2017, July 3). Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: Comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al. Arthritis Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/s13075-017-1362-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free